A randomized placebo-controlled trial of dehydroepiandrosterone (DHEA) [prasterone] treatment for two months before starting ovulation induction for in vitro fertilization (IVF)
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Prasterone (Primary) ; Urofollitropin
- Indications Female infertility
- Focus Therapeutic Use
- 04 Apr 2008 Status changed from recruiting to terminated based on ClinicalTrials.gov information.
- 02 Apr 2008 Biomarkers information updated
- 06 Feb 2007 New trial record.